We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byJarno Mikkola
Modified over 4 years ago
Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B. Leighl, MD, MS, Samuel R.G. Finlayson, MD, MPH, Thomas K. Varghese, MD, MS, Gail E. Darling, MD The Annals of Thoracic Surgery Volume 103, Issue 5, Pages (May 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
The Annals of Thoracic Surgery 2017 103, 1647-1653DOI: (10. 1016/jThe Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier survival curves stratified by pathologic nodal stage: (A) all patients (log-rank [LR] test p = 0.15); (B) pathologic N0 (LR test p = 0.41); (C) pathologic N1 (LR test p = 0.008); and (D) pathologic N2 (LR test p < ). (AMR = adjuvant mediastinal radiotherapy; CI = confidence interval.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Subpopulation analysis. Kaplan-Meier survival curves, stratified by procedure, for node- and margin-negative patients: (A) lobectomy (log-rank test p = 0.25), and (B) sublobar resections (log-rank test p = 0.08). (AMR = adjuvant mediastinal radiotherapy; CI = confidence interval.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer
Thomas J. Birdas, MD, Richard P. M
Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Chun Chieh Lin, PhD, MBA, Matthew P
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Joshua E. Rosen, BASc, Hari B
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S
Invasive Mediastinal Staging Guideline Concordance
Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma Jeeyun Lee, MD, Kyoung-Eun.
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Long-Term Outcome After Resection of Non-Small Cell Lung Cancer Invading the Thoracic Inlet Stéphane Collaud, MD, MS, Tiago Machuca, MD, PhD, Olaf Mercier,
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
© 2023 SlidePlayer.com Inc. All rights reserved.